‘I don’t have any friends’: why do young people today have fewer mates? - The Guardian

News|Articles|October 15, 2026 ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates. Automated breast ultrasound (ABUS) detected breast cancer at a rate similar to handheld ultrasound (HHUS) in women with dense breasts while producing fewer abnormal interpretations, fewer false-positive initial assessments, and fewer recommendations for short-interval follow-up, according to an observational study published in the October 2026 issue of the Journal of the American College of Radiology. The analysis, drawn from more than 25,000 supplemental screening examinations in US community practice, was not designed to establish sensitivity or specificity, and ABUS may not be appropriate for every patient with dense breast tissue. According to the investigators and an accompanying news release, this is the first study to directly compare the screening performance of the 2 modalities in clinical practice in the United States. Why does supplemental ultrasound screening matter for patients with dense breasts?

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.